|
SINCALIDE
 INN SINCALIDE
|
cas 25126-32-3 |
CLASS VARIOUS DIAGNOSTIC IMAGING CHOLERETIC SYNTHETICALLY-PREPARED C-TERMINAL OCTAPEPTIDE OF CHOLECYSTOKININ CHOLECYSTOPANCREATIC-GASTROINTESTINAL HORMONE PEPTIDE FOR PARENTERAL ADMINISTRATION |
|
ATC code
V04CC03 |
|
Target - |
DrugCentral Cholecystokinin receptor type A UNIPROT P32238 CCKAR |
Download SDF file |
Cholecystokinin-8 Formula: C49H62N10O16S3 Calculated chemical properties: MW 1141.28 NB_atoms 78 XLogP -4.00 PSA 392.289 NB_HD 13 NB_HA 26 fsp3 0.39 Lipinski(0=no;1=yes) 0 |
FDA NDA 017697 ( label) INN (SINCALIDE) KINEVAC (BRACCO) APPROVAL= AP YEAR= 1976 NDA 210850 ( label) INN (SINCALIDE) SINCALIDE (MAIA PHARMS INC) APPROVAL= AP YEAR= 2022 |
Other links: PubChem ChemicalProbes U.S. repository of Clinical Trials VigiAccess SIDER side effects ChemSynthesis Patent@SureChEMBL |